Abstract
An American physician-traveler to East Africa presented with manifestations of cerebral malaria and was treated with intravenous quinidine for chloroquine-resistant falciparum malaria. He later relapsed with Plasmodium ovale infection, despite previous primaquine therapy. Treatment of chloroquine-resistant malaria is discussed. The difficulty in diagnosing P. ovale infections and the predominance of this malaria species over P. vivax in East Africa are reviewed.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bia F. J., Barry M. Parasitic infections of the central nervous system. Neurol Clin. 1986 Feb;4(1):171–206. [PubMed] [Google Scholar]
- Bruce-Chwatt L. J. Terminology of relapsing malaria: enigma variations. Trans R Soc Trop Med Hyg. 1984;78(6):844–845. doi: 10.1016/0035-9203(84)90042-7. [DOI] [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Imported malaria among travelers--United States. MMWR Morb Mortal Wkly Rep. 1984 Jul 13;33(27):388–390. [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb Mortal Wkly Rep. 1985 Apr 12;34(14):185-90, 195. [PubMed] [Google Scholar]
- Centers for Disease Control (CDC) Update: chloroquine-resistant Plasmodium falciparum--Africa. MMWR Morb Mortal Wkly Rep. 1983 Aug 26;32(33):437–438. [PubMed] [Google Scholar]
- Chin W., Coatney G. R. Relapse activity in sporozoite-induced infections with a West African strain of Plasmodium ovale. Am J Trop Med Hyg. 1971 Nov;20(6):825–827. doi: 10.4269/ajtmh.1971.20.825. [DOI] [PubMed] [Google Scholar]
- Harwin R. M. Malaria due to Plasmodium ovale in Rhodesia. Cent Afr J Med. 1971 Jul;17(7):146–148. [PubMed] [Google Scholar]
- Lysenko A. J., Beljaev A. E. An analysis of the geographical distribution of Plasmodium ovale. Bull World Health Organ. 1969;40(3):383–394. [PMC free article] [PubMed] [Google Scholar]
- Miller L. H., Mason S. J., Clyde D. F., McGinniss M. H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976 Aug 5;295(6):302–304. doi: 10.1056/NEJM197608052950602. [DOI] [PubMed] [Google Scholar]
- Phillips R. E., Warrell D. A., White N. J., Looareesuwan S., Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. doi: 10.1056/NEJM198505163122001. [DOI] [PubMed] [Google Scholar]
- Weniger B. G., Blumberg R. S., Campbell C. C., Jones T. C., Mount D. L., Friedman S. M. High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya. N Engl J Med. 1982 Dec 16;307(25):1560–1562. doi: 10.1056/NEJM198212163072506. [DOI] [PubMed] [Google Scholar]
- White N. J., Looareesuwan S., Warrell D. A., Chongsuphajaisiddhi T., Bunnag D., Harinasuta T. Quinidine in falciparum malaria. Lancet. 1981 Nov 14;2(8255):1069–1071. doi: 10.1016/s0140-6736(81)91275-7. [DOI] [PubMed] [Google Scholar]
- White N. J., Looareesuwan S., Warrell D. A. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):173–175. doi: 10.1097/00005344-198303000-00001. [DOI] [PubMed] [Google Scholar]
- Wyler D. J. Malaria--resurgence, resistance, and research (second of two parts). N Engl J Med. 1983 Apr 21;308(16):934–940. doi: 10.1056/NEJM198304213081605. [DOI] [PubMed] [Google Scholar]